Nature Reviews Urology

Article	Citations
CDH12-expressing cell population predicts patient response to therapy	156
Krause corpuscles act as genital vibration detectors	146
Exploratory results from the CheckMate 214 trial	122
Immune infiltration associated with outcomes	93
Semen quality recovery following COVID-19	77
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	70
Texture analysis for patient selection	66
Single-cell and spatial sequencing of kidney cancer	59
Sexual recovery interventions following prostate cancer treatment	58
Human-relevant urothelial model provides insight into infection strategies and host response	58
Time for women-centred gynaecology	57
PARP inhibitors plus enzalutamide to treat mCRPC	53
RAL-P in infants: expert tips for success	53
High-dose chemotherapy for relapsed testicular germ cell tumours	53
A clinical guide to rare male sexual disorders	52
Urine microbiota differ in bladder cancer	52
HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity	51
Preclinical models of bladder cancer: BBN and beyond	49
Considering urology in a planetary context	48
Advancing the state of the art in congenital obstructive uropathy	46
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer	46
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer	45
Host–biomaterial interactions in mesh complications after pelvic floor reconstructive surgery	43
Proteomic-based analysis of testicular interstitial fluid	43
Prevalence of gender dysphoria in Japan	42

FOXA2–KIT-driven lineage plasticity in NEPC	42
Microfluidic sperm selection	41
Madrid plays host to a celebration of urology	38
A new text message-based platform for self-management of patients with IC/BPS	38
What happens in Vegas … shapes the future of urology	37
Promise without practice — charting the path forward for bladder cancer biomarkers	36
Reducing the stigma of academic mental health can save lives	36
Is SARS-CoV-2-induced testicular damage in hamsters relevant?	36
Ibrexafungerp to treat acute vulvovaginal candidiasis	36
Galectins as potential therapeutic targets in STIs in the female genital tract	35
Overcoming antibiotic resistance in complicated UTI	35
Metaverse in surgery — origins and future potential	34
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	33
Evolution of the World Health Organization semen analysis manual: where are we?	33
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	33
A non-invasive assay for UTUC diagnosis	32
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	32
Pembrolizumab + axitinib beyond first-line therapy for mRCC	31
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	31
Resolving the puzzle of same-sex sexual interactions	31
Measuring and improving the cradle-to-grave environmental performance of urological procedures	29
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	29
The mechanism of action of neuromodulation in the treatment of overactive bladder	29
Vaccination to prevent untreatable gonorrhoea	28
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	28
COVID can’t kill CopMich collaboration	28
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	28
Efficacy of the Revi system in treating urgency urinary incontinence	28
Is it time to rethink the current patient-reported outcome measures?	26
PEACEing together prostate cancer therapy	26
Effect of high glucose on E. coli	26
Personalized 3D models for prostate cancer surgery	26
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	26
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	26
Sexual orientation, gender identity and COVID: a complicated picture	25
Secondary kidney stones — remove or leave?	24
The magic of MagSToNE	23
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	23
Cribriform morphology affects mpMRI imaging	23
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	22
Women in urology: the past	22
AUA returns to its former glory in Chicago	22
Successful mentorship for women in urology — a new era	22
Microultrasonography-guided prostate cancer biopsy	21
A clinical overview of people living with HIV and genitourinary cancer care	21
Videourodynamics — role, benefits and optimal practice	21
Prostate cancer in transgender women — challenges in research and clinical care	21
Promising efficacy of UTI vaccines as an alternative to antibiotics	21
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	20
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	20

Robots learning to imitate surgeons — challenges and possibilities	20
The placebo and nocebo effects in functional urology	20
Current and emerging strategies to curb antibiotic-resistant urinary tract infections	19
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	19
Androgen receptor pathway inhibitor combination in prostate cancer	18
Metabolic response to immunotherapy in prostate cancer	17
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	16
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	15
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	15
De-clear cell differentiated renal cell carcinoma — a new therapeutic target	15
The future of patient-derived xenografts in prostate cancer research	15
Management and cost of stent encrustation in pregnancy	15
Immune-based therapies in penile cancer	14
Pride, not prejudice	14
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	13
The evolving treatment landscape of metastatic urothelial cancer	13
Turning up the heat: CTLA4 blockade in urothelial cancer	13
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective	12
The value of women urologists — individual and institutional imperatives to address salary equity	12
The prognostic role of stroma in UTUC	12
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	11
The unclear role of PET–CT in localized radiorecurrent prostate cancer	11
Uncovering a link between COVID-19 and renal cell carcinoma	11
We all get erections — de-gendering sexual arousal dysfunction in the ICD	11
The shifting treatment paradigm of metastatic renal cell carcinoma	10
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	10
Prostate cancer screening: a new way forward or another false start?	10
Hallmark discoveries in the biology of Wilms tumour	10
Improved phenotypic classification of male infertility to promote discovery of genetic causes	10
Turning back time in the testes	10
Understanding iGCA	9
BAUSing back in Birmingham	9
CMA mediates resistance to androgen inhibitors in prostate cancer	9
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	9
Mitomycin C plus cytosine arabinoside for NMIBC	9
Power up to investigate PrEP	8
Metabolism, mitochondria and metastasis in kidney cancer	8
Effects of COVID-19 vaccine on semen parameters	8
Tuft cells in prostate cancer	8
Diagnosis of ccRCC	8
Men hold the balance of power	8
Patient selection is key in IMbassador250	8
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	8
Salvage therapy for prostate cancer after radical prostatectomy	7
Male infertility and somatic health — insights into lipid damage as a mechanistic link	7
Microbiota manipulation to prevent oxalate kidney stone formation	7
Genetic ancestry and racial differences in prostate tumours	7
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	7
Spatiotemporal trends in human semen quality	7
Semen parameters across testicular cancer stages	7
MRI diagnosis and radical prostatectomy outcomes	7
The ins and outs of penile erection	7
Mellow yellow: BilR reduces bilirubin to urobilinogen	7
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	7
Mechanisms of the Supra-T paradox	7
Sperm activity affected by endometriosis	7
Advances in sliding clip renorrhaphy for partial nephrectomy	7
Chlorination by-products in drinking water — association with bladder cancer risk	6
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS	6
Practical considerations for prostate hypofractionation in the developing world	6
Toilet-based continuous health monitoring using urine	6
Stepping up to prevent bacterial vaginosis recurrence	6
Syphilis on the rise — a need for alternative therapies and vaccines	6
Prostate luminal progenitor cells: from mouse to human, from health to disease	5
Clinical trial design for non-muscle-invasive bladder cancer	5
Influence of substance use on male reproductive health and offspring outcomes	5
Author Correction: Advances in sperm analysis: techniques, discoveries and applications	5
The future of pelvic lymph node dissection for urological malignancies	5
Genetic and biological drivers of prostate cancer disparities in Black men	5
Testosterone replacement therapy and spermatogenesis in reproductive age men	5
Particulate matter leaves a bitter taste in testes	5
Artificial intelligence in the management of prostate cancer	5
Pregnancy and parental leave in medicine and academia — a focus on urology	5
The effects of diet on prostate cancer outcomes	5
ADT intensification to treat biochemically recurrent prostate cancer	5
Pronouns in English: a user’s guide	5
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	5
Urology on a changing planet: links between climate change and urological disease	5
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma	5
Feasibility and potential of an MRI-based prostate cancer screening	5

Prescribing clinician specialty influences adherence to PrEP

5